Back

SYMPLICITY HTN-3 screen failure patient cohort analysis

28 August 2016 (11:54 - 12:12)
Organised by:
Congress Presentation Part of: Resistant hypertension Treatment of hypertension ESC Premium Access ESC Congress 2016

About the speaker

Photo
Professor Ron Waksman

Washington Hospital Center & Medstar Health, Washington, DC (United States of America)

4 More presentations in this session

Presentation thumbnail
State of the art in treatment of resistant hypertension.
Professor R. Schmieder (Erlangen, DE)
Slides Video
Presentation thumbnail
Novel Designer Natriuretic Peptide (ZD100) in Human Resistant-Like Hypertension - A First in Human Study
Professor H. Chen (Rochester, US)
Abstract Slides Video
Presentation thumbnail
The role of adding spironolactone and renal denervation in true resistant hypertension. one-year outcomes of randomized study.
Doctor J. Rosa (Nymburk, CZ)
Abstract Slides Video
Presentation thumbnail
Future direction for research in management of resistant hypertension.
Professor A. Pathak (Luxembourg, LU)
Slides Video

Access the full session

Session thumbnail
Resistant hypertension

The Event

Event poster

ESC Congress 2016

28 August 2016 11:54 CET
You may be interested in
thumbnail
Congress Session
Lead extraction
1 April 2025
thumbnail
Congress Presentation
Application of win ratio methodology in the Global SYMPLICITY Registry for patients with atrial fibrillation or obstructive sleep apnea
27 August 2021
thumbnail
Congress Presentation
Initial evidence of a new telemonitoring device reliably capturing lower leg volume automatically over 15 months in the field
29 June 2021
thumbnail
Congress Presentation
Clinical outcomes and risk factors associated with drug-coated balloon treatment for femoropopliteal artery disease in patients on maintenance hemodialysis
25 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources